Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Anfossi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Radiation Oncology (London, England)|October 22, 2013
Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure patternYong Bao, ShiLiang Liu, QiChao Zhou, et al.
Gynecologic Oncology|August 7, 2004
The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cellsAlessandro D Santin, Stefania Cane', Stefania Bellone, et al.
Cancer|October 30, 2003
The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinomaAlessandro D Santin, Stefania Cane', Stefania Bellone, et al.
Cancer|January 2, 2009
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.
American Journal of Obstetrics and Gynecology|November 4, 2008
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.
Expert Review of Anticancer Therapy|May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
Annals of Surgical Oncology|November 3, 2016
Prognostic Factors for Locoregional Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma Treated with Radical Two-Field Lymph Node Dissection: Results from Long-Term Follow-UpShiLiang Liu, Simone Anfossi, Bo Qiu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 27, 2015
Breast cancer circulating biomarkers: advantages, drawbacks, and new insightsAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.
Molecular Cancer|October 21, 2024
MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2Simone Anfossi, Faezeh Darbaniyan, Joseph Quinlan, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Radiation Oncology (London, England)|October 22, 2013
Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure patternYong Bao, ShiLiang Liu, QiChao Zhou, et al.
Gynecologic Oncology|August 7, 2004
The serine protease stratum corneum chymotryptic enzyme (kallikrein 7) is highly overexpressed in squamous cervical cancer cellsAlessandro D Santin, Stefania Cane', Stefania Bellone, et al.
Cancer|October 30, 2003
The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinomaAlessandro D Santin, Stefania Cane', Stefania Bellone, et al.
Cancer|January 2, 2009
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.
American Journal of Obstetrics and Gynecology|November 4, 2008
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancerStefania Bellone, Simone Anfossi, Timothy J O'Brien, et al.
Expert Review of Anticancer Therapy|May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
Annals of Surgical Oncology|November 3, 2016
Prognostic Factors for Locoregional Recurrence in Patients with Thoracic Esophageal Squamous Cell Carcinoma Treated with Radical Two-Field Lymph Node Dissection: Results from Long-Term Follow-UpShiLiang Liu, Simone Anfossi, Bo Qiu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 27, 2015
Breast cancer circulating biomarkers: advantages, drawbacks, and new insightsAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.
Molecular Cancer|October 21, 2024
MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2Simone Anfossi, Faezeh Darbaniyan, Joseph Quinlan, et al.
Pageof 4